195 related articles for article (PubMed ID: 25526734)
1. Imaging of gliomas at 1.5 and 3 Tesla - A comparative study.
Tselikas L; Souillard-Scemama R; Naggara O; Mellerio C; Varlet P; Dezamis E; Domont J; Dhermain F; Devaux B; Chrétien F; Meder JF; Pallud J; Oppenheim C
Neuro Oncol; 2015 Jun; 17(6):895-900. PubMed ID: 25526734
[TBL] [Abstract][Full Text] [Related]
2. Target definition for malignant gliomas: no difference in radiation treatment volumes between 1.5T and 3T magnetic resonance imaging.
Guarnaschelli JN; Vagal AS; McKenzie JT; McPherson CM; Warnick RE; Batra V; Breneman JC; Lamba MA
Pract Radiat Oncol; 2014; 4(5):e195-e201. PubMed ID: 25194105
[TBL] [Abstract][Full Text] [Related]
3. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
[TBL] [Abstract][Full Text] [Related]
4. Multicontrast black-blood MRI of carotid arteries: comparison between 1.5 and 3 tesla magnetic field strengths.
Yarnykh VL; Terashima M; Hayes CE; Shimakawa A; Takaya N; Nguyen PK; Brittain JH; McConnell MV; Yuan C
J Magn Reson Imaging; 2006 May; 23(5):691-8. PubMed ID: 16555259
[TBL] [Abstract][Full Text] [Related]
5. Low-grade gliomas: do changes in rCBV measurements at longitudinal perfusion-weighted MR imaging predict malignant transformation?
Danchaivijitr N; Waldman AD; Tozer DJ; Benton CE; Brasil Caseiras G; Tofts PS; Rees JH; Jäger HR
Radiology; 2008 Apr; 247(1):170-8. PubMed ID: 18372467
[TBL] [Abstract][Full Text] [Related]
6. Reproducibility of dynamic contrast-enhanced MRI and dynamic susceptibility contrast MRI in the study of brain gliomas: a comparison of data obtained using different commercial software.
Conte GM; Castellano A; Altabella L; Iadanza A; Cadioli M; Falini A; Anzalone N
Radiol Med; 2017 Apr; 122(4):294-302. PubMed ID: 28070841
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy of automatic normalization of CBV in glioma grading using T1- weighted DCE-MRI.
Sahoo P; Gupta RK; Gupta PK; Awasthi A; Pandey CM; Gupta M; Patir R; Vaishya S; Ahlawat S; Saha I
Magn Reson Imaging; 2017 Dec; 44():32-37. PubMed ID: 28827098
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of cerebral gliomas using rCBV measurements during sequential acquisition of T1-perfusion and T2*-perfusion MRI.
Saini J; Gupta RK; Kumar M; Singh A; Saha I; Santosh V; Beniwal M; Kandavel T; Cauteren MV
PLoS One; 2019; 14(4):e0215400. PubMed ID: 31017934
[TBL] [Abstract][Full Text] [Related]
9. Amide proton transfer-weighted MRI in the clinical setting - correlation with dynamic susceptibility contrast perfusion in the post-treatment imaging of adult glioma patients at 3T.
Friismose AI; Markovic L; Nguyen N; Gerke O; Schulz MK; Mussmann BR
Radiography (Lond); 2022 Feb; 28(1):95-101. PubMed ID: 34509365
[TBL] [Abstract][Full Text] [Related]
10. Initial experience of 3 Tesla versus conventional field strength magnetic resonance imaging of small functioning pituitary tumours.
Stobo DB; Lindsay RS; Connell JM; Dunn L; Forbes KP
Clin Endocrinol (Oxf); 2011 Nov; 75(5):673-7. PubMed ID: 21609346
[TBL] [Abstract][Full Text] [Related]
11. Contrast-enhanced radial 3D fat-suppressed T1-weighted gradient-recalled echo sequence versus conventional fat-suppressed contrast-enhanced T1-weighted studies of the head and neck.
Wu X; Raz E; Block TK; Geppert C; Hagiwara M; Bruno MT; Fatterpekar GM
AJR Am J Roentgenol; 2014 Oct; 203(4):883-9. PubMed ID: 25247956
[TBL] [Abstract][Full Text] [Related]
12. Observer variability of reference tissue selection for relativecerebral blood volume measurements in glioma patients.
Oei MTH; Meijer FJA; Mordang JJ; Smit EJ; Idema AJS; Goraj BM; Laue HOA; Prokop M; Manniesing R
Eur Radiol; 2018 Sep; 28(9):3902-3911. PubMed ID: 29572637
[TBL] [Abstract][Full Text] [Related]
13. Comparing the volume of gliomas in the brain in FLAIR and post-contrast T1-weighted MRI sequences.
Gurwara S; Azzawe A; Jacobs S; Ravi A; Hardjasudarma M; Toledo EG
J La State Med Soc; 2010; 162(5):265-6. PubMed ID: 21141258
[TBL] [Abstract][Full Text] [Related]
14. Pathological factors contributing to crossed cerebellar diaschisis in cerebral gliomas: a study combining perfusion, diffusion, and structural MR imaging.
Liu X; Li J; Xu Q; Mantini D; Wang P; Xie Y; Weng Y; Ma C; Sun K; Zhang Z; Lu G
Neuroradiology; 2018 Jun; 60(6):643-650. PubMed ID: 29666881
[TBL] [Abstract][Full Text] [Related]
15. Comparison between contrast-enhanced magnetic resonance imaging and technetium 99m glucohepatonic acid single photon emission computed tomography with histopathologic correlation in gliomas.
Kumar RA; Khandelwal N; Sodhi KS; Pathak A; Mittal BR; Radotra BD; Suri S
J Comput Assist Tomogr; 2006; 30(5):723-33. PubMed ID: 16954918
[TBL] [Abstract][Full Text] [Related]
16. Normal findings on brain fluid-attenuated inversion recovery MR images at 3T.
Neema M; Guss ZD; Stankiewicz JM; Arora A; Healy BC; Bakshi R
AJNR Am J Neuroradiol; 2009 May; 30(5):911-6. PubMed ID: 19369605
[TBL] [Abstract][Full Text] [Related]
17. Perfusion, diffusion and spectroscopy values in newly diagnosed cerebral gliomas.
Catalaa I; Henry R; Dillon WP; Graves EE; McKnight TR; Lu Y; Vigneron DB; Nelson SJ
NMR Biomed; 2006 Jun; 19(4):463-75. PubMed ID: 16763973
[TBL] [Abstract][Full Text] [Related]
18. Comparison of T1-weighted fast spin-echo and T1-weighted fluid-attenuated inversion recovery images of the lumbar spine at 3.0 Tesla.
Lavdas E; Vlychou M; Arikidis N; Kapsalaki E; Roka V; Fezoulidis IV
Acta Radiol; 2010 Apr; 51(3):290-5. PubMed ID: 20170294
[TBL] [Abstract][Full Text] [Related]
19. Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease.
Seeger A; Braun C; Skardelly M; Paulsen F; Schittenhelm J; Ernemann U; Bisdas S
Acad Radiol; 2013 Dec; 20(12):1557-65. PubMed ID: 24200483
[TBL] [Abstract][Full Text] [Related]
20. Single-Dose Gadoterate Meglumine for 3T Late Gadolinium Enhancement MRI for the Assessment of Chronic Myocardial Infarction: Intra-Individual Comparison with Conventional Double-Dose 1.5T MRI.
Lim J; Park EA; Song YS; Lee W
Korean J Radiol; 2018; 19(3):372-380. PubMed ID: 29713214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
